| Literature DB >> 32967252 |
MunHee Kim1, Wi-Young So2, Jiyoun Kim3.
Abstract
This study aimed to examine the relationships between activity restriction, quality of life (QoL), and hematopoietic profile in breast cancer survivors according to exercise modality. The subjects in this study were 187 female breast cancer survivors among a total of 32,631 participants in the Korea National Health and Nutrition Examination Survey, which was conducted from 2016 to 2018. The selected subjects participated in a questionnaire survey and blood analysis. A cross-analysis was conducted to determine the relationship between participation in various modality of exercise (e.g., aerobic exercise, resistance exercise, walking exercise). The phi coefficients or Cramer's V value for activity restriction and QoL were calculated; an independent t-test was conducted to evaluate the differences between hematopoietic profiles based on the modality of exercise. Statistically significant correlations were seen between obesity and aerobic exercise and walking frequency, as well as between diabetes and aerobic exercise and activity restriction. With respect to QoL, there was a statistically significant correlation between participation in aerobic exercise and exercise ability, participation in aerobic exercise and anxiety/depression, participation in resistance exercise and subjective health status, participation in resistance exercise and exercise ability, and participation in weekly walking exercise and self-care ability. Regarding hemodynamic changes, red blood cells increased significantly in breast cancer survivors who participated in weekly resistance exercise compared to in those who did not. In conclusion, exercise participation had a positive effect on activity restriction, QoL, and hematopoietic profile in breast cancer survivors; in particular, some modalities of aerobic exercise were more effective.Entities:
Keywords: aerobic exercise; obesity; resistance exercise; subjective health status; walking
Mesh:
Year: 2020 PMID: 32967252 PMCID: PMC7559845 DOI: 10.3390/ijerph17186899
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
The characteristics of the study subjects.
| Variables | Mean ± Standard Deviation |
|---|---|
| Breast cancer survivor ( | 187 |
| Age (years) | 60.8 ± 11.1 |
| Breast cancer diagnosis age (years) | 54.5 ± 11.3 |
| Menarche age (years) | 14.3 ± 1.8 |
| Menopause age (years) | 48.00 ± 4.9 |
| Height (cm) | 155.8 ± 6.1 |
| Weight (kg) | 57.5 ± 8.3 |
Correlation between exercise modality and activity restriction-related variants in breast cancer survivors.
| Aerobic Exercise | Resistance Exercise | Walking | ||||||
|---|---|---|---|---|---|---|---|---|
| Yes | No | Yes | No | 1–2/Wk. | 3–5/Wk. | 6–7/Wk. | ||
| Discomfort in the last 2 weeks | Yes | 10.8% (20) | 18.3% (34) | 4.81% (9) | 24.5% (46) | 12.6% (15) | 10.9% (13) | 9.2% (11) |
| No | 32.3% (60) | 38.7% (72) | 13.9% (26) | 56.9% (106) | 21.0% (25) | 27.7% (33) | 18.5% (22) | |
| Phi coefficients | 0.077 | 0.039 | 0.084 | |||||
| Presence of disease in the last month | Yes | 5.9% (11) | 4.3% (8) | 2.7% (5) | 8.0% (15) | 5.0% (6) | 5.9% (7) | 2.5% (3) |
| No | 37.1% (69) | 53.7% (98) | 16.0% (30) | 73.2% (137) | 28.6% (34) | 32.8% (39) | 25.2% (30) | |
| Phi coefficients | 0.101 | 0.056 | 0.079 | |||||
| Presence of disease in the last year | Yes | 13.1% (8) | 16.4% (10) | 3.2% (2) | 24.2% (16) | 15.8% (6) | 13.2% (5) | 5.3% (2) |
| No | 39.3% (24) | 31.1% (19) | 24.6% (15) | 45.9% (28) | 13.2% (5) | 23.7% (9) | 28.9% (11) | |
| Phi coefficients | 0.104 | 0.242 | 0.130 | |||||
| Presence of absenteeism in the last month | Yes | 5.3% (4) | 2.7% (2) | 2.7% (2) | 5.3% (4) | 3.8% (2) | 3.8% (2) | 3.8% (2) |
| No | 36.0% (27) | 56.0% (42) | 13.3% (10) | 78.7% (59) | 32.1% (17) | 29.3% (15) | 28.3% (15) | |
| Phi coefficients | −0.152 | −0.101 | 0.019 | |||||
| Presence of absenteeism in the last year | Yes | 0.0% (0) | 11.1% (3) | 0.0% (0) | 16.7% (5) | 15.0% (3) | 0.0% (0) | 0.0% (0) |
| No | 37.0% (10) | 51.9% (14) | 10.0% (3) | 63.3% (19) | 25.0% (5) | 25.0% (5) | 35.0% (7) | |
| Phi coefficients | 0.356 | 0.210 | 0.437 | |||||
| Obesity | Underweight | 0.5% (1) | 2.2% (4) | 0.0% (0) | 3.2% (3) | 0.8% (1) | 2.3% (4) | 0.0% (0) |
| Normal | 25.8% (48) | 29.5% (55) | 8.4% (8) | 44.2% (42) | 16.8% (20) | 22.7% (27) | 16.8% (20) | |
| Pre-obesity | 11.8% (22) | 9.1% (17) | 5.3% (5) | 15.8% (15) | 5.9% (7) | 5.9% (7) | 10.0% (12) | |
| Obesity | 4.8% (9) | 16.1% (30) | 2.1% (7) | 21.1% (20) | 10.1% (12) | 6.7% (8) | 0.8% (1) | |
| Cramer’s V | 0.246 * | 0.158 | 0.290 * | |||||
| Presence of diabetes | Normal | 25.5% (40) | 36.3% (57) | 14.5% (23) | 47.7% (75) | 18.4% (19) | 30.1% (31) | 22.3% (23) |
| IGT | 15.9% (25) | 8.9% (14) | 5.0% (8) | 19.6% (31) | 8.7% (9) | 7.7% (8) | 2.9% (3) | |
| Diabetes | 5.1% (8) | 8.3% (13) | 0.6% (1) | 12.7% (20) | 2.9% (3) | 3.9% (4) | 2.9% (3) | |
| Cramer’s V. | 0.204 * | 0.177 | 0.487 | |||||
| Presence of anemia | Yes | 39.1% (63) | 50.3% (81) | 7.5% (28) | 72.5% (116) | 26.7% (28) | 35.2% (37) | 30.5% (32) |
| No | 6.2% (10) | 4.3% (7) | 1.8% (3) | 8.7% (14) | 2.9% (3) | 4.7% (5) | 0.0% (0) | |
| Phi coefficients | 0.093 | 0.159 | 0.141 | |||||
IGT: impaired glucose tolerance; * p < 0.05; cross-analysis.
Correlation between exercise modality, subjective health status and QoL in breast cancer survivors.
| Aerobic Exercise | Resistance Exercise | Walking | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Yes | No | Yes | No | 1–2/Wk. | 3–5/Wk. | 6–7/Wk. | |||
| Subjective health status | Very Good | 2.7% (5) | 1.1% (2) | 1.1% (2) | 2.7% (5) | 0.0% (0) | 0.0% (0) | 0.0% (0) | |
| Good | 7.0% (13) | 7.0% (15) | 1.6% (3) | 13.4% (25) | 4.2% (5) | 8.4% (10) | 3.4% (4) | ||
| Normal | 25.3% (47) | 28.5% (53) | 14.4% (27) | 39.0% (73) | 16.8% (20) | 18.5% (22) | 15.7% (19) | ||
| Bad | 5.4% (10) | 12.4% (23) | 1.1% (2) | 16.6% (31) | 6.7% (6) | 8.4% (10) | 5.9% (7) | ||
| Very bad | 2.7% (5) | 7.0% (13) | 0.5% (1) | 9.6% (18) | 7.6% (9) | 3.4% (4) | 2.5% (3) | ||
| Cramer’s V | 0.194 | 0.252 * | 0.401 | ||||||
| QoL | Mobility | No difficulty walking | 37.0% (69) | 40.3% (75) | 17.6% (33) | 59.4% (111) | 22.7% (27) | 31.0% (37) | 21.8% (26) |
| Walking is a bit difficult | 5.9% (11) | 15.1% (28) | 1.1% (2) | 19.8% (37) | 7.6% (9) | 7.6% (9) | 5.8% (7) | ||
| Lying all day | 0.0% (0) | 1.6% (3) | 0.0% (0) | 2.1% (4) | 3.4% (4) | 0.0% (0) | 0.0% (0) | ||
| Cramer’s V | 0.196 * | 0.198 * | 0.189 | ||||||
| Self-care | No problems taking a bath/dressing | 53.2% (99) | 42.5% (79) | 18.7% (35) | 76.5% (143) | 28.6% (34) | 37.8% (45) | 26.9% (32) | |
| Taking a bath/dressing somewhat hindered | 3.2% (8) | 0.5% (1) | 0.0% (0) | 4.3% (8) | 5.0% (6) | 0.8% (1) | 0.8% (1) | ||
| Not able to take a bath/dress alone | 0.5% (1) | 0.0% (0) | 0.0% (0) | 0.5% (1) | 0.0% (0) | 0.0% (0) | 0.0% (0) | ||
| Cramer’s V | 0.197 | 0.108 | 0.037 * | ||||||
| Usual | No ADL disruption | 38.1% (71) | 48.9% (91) | 17.6% (33) | 68.9% (129) | 25.2% (30) | 35.3% (42) | 24.4% (29) | |
| ADL is | 4.8% (9) | 8.0% (15) | 1.0% (2) | 12.3% (23) | 8.4% (10) | 3.3% (4) | 3.3% (4) | ||
| Phi coefficients | −0.043 | −0.108 | 0.093 | ||||||
| Pain/ | No pain/ | 27.9% (52) | 37.6% (70) | 13.9% (26) | 51.3% (96) | 18.5% (22) | 27.7% (33) | 17.6% (21) | |
| Some pain/ | 13.4% (25) | 16.3% (30) | 4.3% (8) | 25.7% (48) | 10.9% (13) | 10.1% (12) | 7.5% (9) | ||
| Severe pain/ | 1.6% (3) | 3.2% (6) | 0.5% (1) | 4.3% (8) | 4.2% (5) | 0.8% (1) | 2.5% (3) | ||
| Cramer’s V | 0.785 | 0.093 | 0.136 | ||||||
| Anxiety/ | No anxiety/depression | 39.2% (73) | 45.1% (84) | 66.3% (33) | 66.3% (124) | 26.0% (31) | 34.4% (41) | 23.5% (28) | |
| Some anxiety/ | 2.1% (4) | 10.7% (20) | 1.1% (2) | 12.3% (23) | 5.9% (7) | 4.2% (5) | 2.5% (3) | ||
| Severe anxiety/ | 1.6% (3) | 1.0% (2) | 0.0% (0) | 2.7% (5) | 1.7% (2) | 0.0% (0) | 1.7% (2) | ||
| Cramer’s V | 0.209 * | 0.138 | 0.132 | ||||||
* p < 0.05, tested by cross-analysis.
Differences between exercise modality participation in relation to hemodynamic variables in breast cancer survivors.
| Variables | Aerobic Exercise | Resistance Exercise | Walking | ||||
|---|---|---|---|---|---|---|---|
| Yes | No | Yes | No | 1–2/Wk. | 3–5/Wk. | 6–7/Wk. | |
| White blood cell (Thous/uL) | 5.51 ± 1.30 | 5.57 ± 1.65 | 5.42 ± 1.71 | 5.54 ± 1.49 | 5.86 ± 1.92 | 5.12 ± 1.35 | 5.60 ± 1.22 |
| Red blood cell (Mil/uL) | 4.27 ± 0.40 | 4.29 ± 0.33 | 4.41 ± 0.38 * | 4.25 ± 0.35 | 4.30 ± 0.37 | 4.33 ± 0.36 | 4.40 ± 0.38 |
| Hemoglobin (g/dL) | 12.97 ± 0.97 | 13.19 ± 0.87 | 12.81 ± 2.50 | 13.05 ± 0.91 | 13.1 ± 1.00 | 13.0 ± 0.93 | 13.35 ± 0.90 |
| Platelets (Thous/uL) | 246.34 ± 64.85 | 233.15 ± 62.36 | 242.65 ± 71.42 | 237.75 ± 64.73 | 220.45 ± 53.27 | 240.45 ± 65.52 | 252.00 ± 73.49 |
| Hematocrit (%) | 39.70 ± 3.00 | 40.36 ± 2.77 | 39.94 ± 5.48 | 39.86 ± 2.84 | 40.08 ± 3.06 | 40.09 ± 2.95 | 40.84 ± 3.03 |
| C-reactive protein (mg/L) | 1.55 ± 2.75 | 1.14 ± 3.01 | 1.18 ± 2.07 | 0.73 ± 0.30 | 0.93 ± 0.92 | 0.78 ± 0.86 | 1.42 ± 3.71 |
* p < 0.05; tested by an independent t-test.